Cardurion Pharmaceuticals vs InterCure
Cardurion Pharmaceuticals
Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics
80 employees · est. 2017 · Burlington, United States
InterCure
Harness the power of respiratory-based treatment for hypertension and heart failure with innovative non-drug solutions
est. 1994
InterCure is the older company (2017 vs 1994).
Side-by-Side Comparison
| Metric | Cardurion Pharmaceuticals | InterCure |
|---|---|---|
| Founded | ||
| Founded | 2017 | 1994 older |
| Headquarters | ||
| Headquarters | Burlington, United States | Not tracked yet |
| Employees | ||
| Employees | 80 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $603.20M | $41.90M |
| Funding Rounds | ||
| Funding Rounds | 5 | 6 |
| Services | ||
| Services | Research and Development of Cardiovascular Drugs, Clinical Programs in PDE9 and CaMKII, In-house Drug Discovery, Clinical Study Evaluation | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Cardiovascular Disease, Healthcare Providers, Pharmaceutical Companies, Biotechnology Investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardurion PharmaceuticalsCardiac Myocyte Signaling PathwaysPDE9 InhibitionCaMKII InhibitionCardiovascular TherapeuticsHeart Failure Treatment +10 | Respiratory-based TreatmentCardiovascular DiseasesPulmonary DiseasesNon-drug TreatmentsHypertensionHeart Failure +8 |
| Website | ||
| Website | cardurion.com | intercure.com |
About Cardurion Pharmaceuticals
Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for its expertise in translating cardiac myocyte signaling pathways into groundbreaking therapeutics, s...
About InterCure
InterCure is a medical device company founded in 1994 that focuses on respiratory-based methods for treating cardiovascular and pulmonary diseases. The company's flagship product, RESpeRATE, is the only FDA-cleared device clinically proven to lower high blood pressure without side effects. In additi...
Also comparing in this category
Comparing more than these two?
Get Cardurion Pharmaceuticals, InterCure and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Cardurion Pharmaceuticals compare?
A PDF of Cardurion Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Cardurion Pharmaceuticals with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cardurion Pharmaceuticals on 12 Sep 2024, and InterCure on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.